Researchers Turn to Adult Stem Cells Biotech firms face skepticism as they try to show that their research can work as medicine and as a business. &lt;FONT face="verdana,MS Sans Serif,arial,helvetica" size="-2" color="#666666"&gt;&lt;B&gt;-The Washington Post&lt;/B&gt;&lt;/FONT&gt;